期刊文献+

PRKN基因突变所致早发型帕金森病家系的临床特征及基因检测

Clinical Characteristics and Genetic Testing of A Pedigree with Early-onset Parkinson's Disease Caused by PRKN Gene Mutation
下载PDF
导出
摘要 目的 探讨2个常染色体隐性遗传早发型帕金森病(autosomal recessive early-onset parkinsonism,AREP)家系中2名患者的临床特征及基因突变情况。方法 对2个中国汉族家庭中共2名患者进行临床资料的收集和基因突变分析。使用靶区捕获和高通量测序筛选与帕金森病(Parkinson’s disease,PD)、震颤、脊髓小脑性共济失调和肌张力障碍等疾病相关的基因;应用多重连接依赖探针扩增(multiples ligation-dependent probe amplification,MLPA)法检测SNCA、LRRK2、PARK2、PINK1、PARK7、ATP13A2、UCHL1、GCH1等基因外显子的重排和大缺失突变。结果 2名临床确诊为PD的患者表现出明显的临床及遗传异质性。基因检测发现家系1的患者存在PRKN基因2号外显子杂合缺失变异和c.619G> T/p.Glu207Ter*杂合变异2种突变,该复合杂合变异与疾病存在家系共分离。家系2的患者存在PRKN基因3~4号外显子纯合缺失变异,且存在LRRK2基因c.4827+6T> A杂合变异及PINK1基因c.1474C> T/p.Arg492*杂合变异;生物信息学分析发现LRRK2基因的c.4827+6T> A变异可能导致其剪切改变。结论 PRKN基因突变所致的早发型帕金森病临床表现及基因突变形式多样;AREP患者可能同时存在多个PD基因致病突变,且其临床发病年龄更早,症状更重更复杂,病情进展更快。 Objective To investigate the clinical characteristics and gene mutations of 2 patients in 2 families of autosomal recessive early-onset Parkinson’s disease(AREP).Methods Clinical data and gene mutation analysis were performed on 2 patients from 2 Chinese Han families.Target capture and high-throughput sequencing were used to screen genes related to Parkinson’s disease(PD),tremor,spinocerebellar ataxia,and dystonia;Multiple ligation-dependent probe amplification(MLPA)was used to detect the rearrangement and large deletion mutations of SNCA,LRRK2,PARK2,PINK1,PARK7,ATP13A2,UCHL1,GCH1 gene exons.Results 2 patients with clinically confirmed PD showed the obvious clinical and genetic heterogeneity.Gene detection found that there were two mutations in the PRKN gene exon 2 heterozygous deletion mutation and c.619G>T/p.Glu207Ter*heterozygous mutation in the patient of family 1.The compound heterozygous mutation was pedigree cosegregated in the family.The patients of pedigree 2 had homozygous deletion mutation in exon 3-4 of PRKN gene,and had heterozygous mutation in LRRK2 gene c.4827+6T>A,and heterozygous mutation in PINK1 gene c.1474C>T/p.Arg492*;Bioinformatics analysis found that the c.4827+6T>A mutation of LRRK2 gene may lead to its shear change.Conclusion The clinical manifestations and gene mutations of early-onset Parkinson’s disease caused by PRKN gene mutations are diverse;AREP patients may have multiple PD gene pathogenic mutations at the same time,and their clinical onset age is earlier,the symptoms are more severe and complex,and the disease progresses are faster.
作者 廖书胜 陈红 刘玫 潘成玉 罗瑷涤 张丽 LIAO Shusheng;CHEN Hong;LIU Mei;PAN Chengyu;LUO Aidi;ZHANG Li(Dept.of Neurology,Liuzhou People’s Hospital Affiliated to Guangxi Medical University,Liuzhou Guangxi 545006;Dept.of Neurology,The Affiliated Hospital of Zunyi Medical University,Zunyi Guizhou 563003,China)
出处 《昆明医科大学学报》 CAS 2023年第5期66-71,共6页 Journal of Kunming Medical University
基金 国家自然科学基金资助项目(82160316,81260177) 贵州省科技厅自然科学基金资助项目[黔科合基础(2019)1351号]。
关键词 早发型帕金森病 PRKN基因 LRRK2基因 PINK1基因 Early onset Parkinson’s disease PRKN gene LRRK2 gene PINK1 gene
  • 相关文献

参考文献2

二级参考文献33

  • 1张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:616
  • 2Zhang ZX, Roman GC, Hong Z,et al. Parkinson's disease inChina: prevalence in Beijing, Xian, and Shanghai[ J]. Lancet,2005,365(9459): 595-597.
  • 3Postuma RB, Berg D, Stem M, et al. MDS clinical diagnosticcriteria for Parkinson、disease[ J]. Mov Disord, 2015,30( 12):1591-1601. DOI: 10.1002/mds.26424.
  • 4Chaudhuri KR, Healy DG, Schapira AH, et al. Non-motorsymptoms of Parkinson's disease : diagnosis and management[ J ].Lancet Neurol, 2006,5(3): 235-245.
  • 5Goetz CG,Tilley BC, Shaftman SR,et al. Movement DisorderSociety-sponsored revision of the Unified Parkinson; s DiseaseRating Scale ( MDS-UPDRS) . scale presentation and clinimetrictesting results [ J ]. Mov Disord, 2008 , 23 ( 15): 2129-2170.DOI: 10.1002/mds. 22340.
  • 6Shah M, Muhammed N, Findley LJ, et al. Olfactory tests in thediagnosis of essential tremor [ J ]. Parkinsonism Relat Disord,2008,14(7) : 563-568. DOI: 10. 1016/j. parkreldis. 2007. 12.006.
  • 7Wenning GK, Shephard B, Hawkes C, et al. Olfactory functionin atypical parkinsonian syndromes [ J ]. Acta NeurologicaScandinavica, 1995,91(4): 247-250.
  • 8Muller A, Mtingersdorf M, Reichmann H, et al. Olfactoryfunction in Parkinsonian syndromes[ J]. J Clin Neurosci, 2002 , 9(5): 521-524.
  • 9Goldstein DS,Holmes C,Bentho O,et al. Biomarkers to detectcentral dopamine deficiency and distinguish Parkinson diseasefrom multiple system atrophy [ J ]. Parkinsonism Relat Disord,2008,14(8): 600-607. DOI: 10. 1016/j. parkreldis. 2008. 01.010.
  • 10Katzenschlager R, Zijlmans J, Evans A, et al. Olfactory functiondistinguishes vascular parkinsonism from Parkinson's disease[ J].J Neurol Neurosurg Psychiatry, 2004, 75(12) : 1749-1752.

共引文献1224

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部